CytoDyn Appoints Jacob Lalezari As CEO, Effective Jan. 26, 2024; Mitchell Cohen Appointed Interim CFO, Effective Feb. 1, 2024
CytoDyn Appoints Jacob Lalezari As CEO, Effective Jan. 26, 2024; Mitchell Cohen Appointed Interim CFO, Effective Feb. 1, 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.